Commandité

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National
Posté
0
147
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Connectez-vous pour aimer, partager et commenter!
Rechercher
Catégories
Lire la suite
Entertainment
Fish Venkat’s family says Prabhas never offered Rs 50 lakh aid
Veteran Telugu actor Fish Venkat, known for his comic roles in numerous films, remains...
Par BharatUpdates 0 2
National
Didn't ask for blocking of Reuters handle, says government as X cries 'censorship'
Par BharatUpdates 0 8
National
Brics rejects EU's unilateral carbon border tax proposal
Par BharatUpdates 0 20
Business
50% on copper, 200% on Pharma: Donald Trump talks of new US tariffs soon; ‘they're going to be tariffed at a very…’
President Trump declared a 50% tariff on copper imports and hinted at a potential 200% tariff on...
Par BharatUpdates 0 25
National
Dassault denies its CEO made comment on Rafale loss during Operation Sindoor
Par BharatUpdates 0 29
© 2025 Dununu.com : Circle of Life - Santan Social Network French
English नेपाली हिन्दी Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Arabic French অসমীয়া বাংলা
DMCA Environ Confidentialité Conditions générale de vente Contactez nous Annuaire